Subscribe to our eNewsletter
|
Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market
POSTED May 5, 2008
EATONTOWN, N.J., April 30 /PRNewswire-FirstCall/ --
Osteotech, Inc. (Nasdaq: OSTE - News), a leader in the emerging field of biologic solutions for regenerative medicine, announced today that it has signed an exclusive distribution agreement with BioHorizons, Inc., effective as of April 1, 2008, under which BioHorizons will market Osteotech's bone regeneration products to the dental market in 29 countries in Europe, the Middle East, Latin America and Asia. Osteotech and BioHorizons previously entered into an agreement for BioHorizons to distribute Osteotech's products to the United States dental market in 2000.
Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer, commented, "Our domestic relationship with BioHorizons has been very successful and we are pleased to be able to expand this relationship overseas. We believe our bone regeneration products are the perfect solution for the new bone grafting procedures being developed to replace missing or extracted teeth with dental implants or as support for dentures, crowns and bridges."
About BioHorizons Implant Systems, Inc.
BioHorizons is a leading oral reconstructive device company at the forefront of digital dentistry. The company has a broad product offering, including surgical planning software, regenerative products, dental implants, CAD/CAM and traditional dental restorations. BioHorizons has a direct sales force in the U.S., Canada, Germany, Spain, United Kingdom, Australia, Mexico, and Chile. Products are distributed in the rest of the world via a network of independent distributors.
www.biohorizons.com
About Implant Logic Systems
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech or this press release, please go to Osteotech's website at www.osteotech.com.
Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of April 30, 2008 and the Company does not intend to update this information.
BioHorizons, Inc.(“BioHorizons”) announced today the completion of its purchase of Implant Logic Systems, Ltd. (“ILS”), first announced on January 30, 2008. Implant Logic Systems will operate as a subsidiary of BioHorizons. Steve Boggan, CEO of BioHorizons, commented, “We are excited to expand our product offering to include VIP Virtual Implant Placement planning software and CAD/CAM surgical guides. This acquisition is a key milestone for us as we move the field of implant dentistry into the digital age.”
For More Information:
Steve Boggan
President and CEO of BioHorizons
205.967.7880
About BioHorizons Implant Systems, Inc.
BioHorizons was founded in 1994 based on technology developed at the University of Alabama at Birmingham. The company has a broad product offering of dental implants including Tapered Internal, Single-stage, Internal, External, One-piece 3.0, and Overdenture. BioHorizons has exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. The company has a direct sales force in the U.S., Canada, Germany, Spain, United Kingdom, Australia, Mexico, and Chile. Products are distributed in the rest of the world via a network of independent distributors.
www.biohorizons.com
About Implant Logic Systems
Implant Logic Systems is leading the dental implant market with innovative, technologically advanced, surgical tools which significantly improve implant placement quality and accessibility for both doctors and patients. Implant Logic Systems operates in the fields of software technology and medical devices to create a revolutionary implant placement technique. This technique is intended to be less invasive to the patient, shorten recovery time, reduce surgery time by up to 75%, and provide a more accurate implant placement. Implant Logic Systems has experienced rapid growth over the past several years. Implant Logic Systems’ computer guided system has proven itself in thousands of clinical surgeries.
www.implantlogic.com
BIRMINGHAM, Alabama, and DUBLIN, California February 21, 2008 /PRNewswire/ --
BioHorizons, Inc. (“BioHorizons” or the “Company”) has been formed to create a leading digital dentistry company in the dental implant market by combining DTI Dental Technologies, Inc. and BioHorizons Implant Systems. The uniqueness stems from expertise in the digital world provided by a large scale dental laboratory and the implant expertise provided by a leading dental implant company.
Digital dentistry is the future of implant dentistry. The sophisticated dental laboratory has almost all of the experience and knowledge of digital data gathering, computer aided design of crowns and abutments, and computer aided manufacturing. Today, virtually no dental implant company has knowledge of or experience with digital technology or its use. Long term, leadership and success in the dental implant industry will go to early adopters who can execute, support, and deliver to dentists a digitally designed and manufactured, complete and customized set of products and tools for each patient procedure. BioHorizons, Inc. will be the first dental implant company in the age of digital dentistry.
BioHorizons’ headquarters will be in Birmingham, Alabama. The combined company generated approximately $150 million in revenues in 2007, making it one of the largest implant dentistry companies in the world. The Company will have 23 operating facilities in North America, eight international facilities and over 1,000 employees. Most importantly, this marriage creates a differentiated restorative dental company that has the most complete product offering in the industry. This provides BioHorizons the ability to streamline the implant and restorative process creating a more efficient continuum of care and superior patient outcomes.
“This development creates a leader in restorative and implant dentistry” stated R. Steven Boggan, President and CEO of BioHorizons. “We are confident that we can decrease treatment times while simultaneously improving patient outcomes. Being the only company with direct experience from surgical planning through final restoration, we offer our current and future customers superior service.”
Wallace Sholdice, President of DTI explained, “We are very excited about this combination. BioHorizons and DTI share a vision for how to move the practice of dentistry into the digital age, especially implant dentistry. We will have the resources and expertise to provide significant value to our customers, particularly through continuing education and marketing programs that only an integrated company like BioHorizons can offer.”
Canaccord Adams acted as financial advisor in the merger.
For More Information:
Steve Boggan
President and CEO of BioHorizons
205.967.7880
About BioHorizons Implant Systems, Inc.
BioHorizons was founded in 1994 based on technology developed at the University of Alabama at Birmingham. The company has a broad product offering of dental implants including Tapered Internal, Single-stage, Internal, External, One-piece 3.0, and Overdenture. BioHorizons has exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. The company has a direct sales force in the U.S., Canada, Germany, Spain, United Kingdom, Australia, Mexico, and Chile. Products are distributed in the rest of the world via a network of independent distributors.
www.biohorizons.com
About DTI
DTI is the only dental laboratory network that provides innovative full practice growth support to dentists who want to excel above the status quo. The Company is a leader in digital dentistry which includes CAD/CAM restorations. Strategically located throughout North America, DTI’s laboratory network extends beyond a simple dental laboratory support as each laboratory represents an epicenter of innovation and artistry for the benefit of each practice we serve.
www.dtidental.com
BIRMINGHAM, Alabama, and Cedarhurst, NEW YORK, January 30, 2008 /PRNewswire/ --
BioHorizons Implant Systems, Inc. announced today its parent company has entered into a definitive agreement to purchase Implant Logic Systems, Ltd. (“ILS”). ILS is a leading innovator and provider of technology solutions for the implant dentistry market. ILS’s Virtual Implant Placement software enables implantologists to view CT scans and create virtual implant treatment plans. Implantologists can then use ILS’s Compu-Guide system to create custom milled surgical guides that bring the virtual treatment plan into the operating suite. Terms of the transaction were not disclosed.
“We are thrilled to add the technology and expertise of ILS to BioHorizons,” stated R. Steven Boggan, President and CEO of BioHorizons. “Our customers have expressed great interest in computer assisted implant treatment planning software and surgical guides. ILS perfectly addresses this customer need. In addition, the Compu-Guide surgical guide system is designed to allow the clinician to place implants more accurately, more quickly and more safely than is otherwise possible. The acquisition of ILS will create significant value for our customers.”
Dr. Michael Klein, President and CEO of ILS, stated, “We are excited about the opportunity to join with BioHorizons. ILS is already well known for its implant planning software and innovative computer guided surgical tools, but our customers will now get the expanded benefits of working with BioHorizons, one of the most progressive and customer-centric companies in the industry.”
For More Information:
Steve Boggan
President and CEO of BioHorizons
205.967.7880
About Implant Logic Systems
Implant Logic Systems is leading the dental implant market with innovative, technologically advanced, surgical tools which significantly improve implant placement quality and accessibility for both doctors and patients. Implant Logic Systems operates in the fields of software technology and medical devices to create a revolutionary implant placement technique. This technique is intended to be less invasive to the patient, shorten recovery time, reduce surgery time by up to 75%, and provide a more accurate implant placement. Implant Logic Systems has experienced rapid growth over the past several years. Implant Logic Systems’ computer guided system has proven itself in thousands of clinical surgeries.
www.implantlogic.com
About BioHorizons
With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. The company has a broad product offering of dental implants including Tapered Internal, Single-stage, Internal, External, One-piece 3.0, and Overdenture. BioHorizons has exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. The company has a direct sales force in the U.S., Canada, Germany, Spain, United Kingdom, Australia, Mexico, and Chile. Products are distributed in the rest of the world via a network of independent distributors. The Company was purchased by HealthpointCapital in 2006.
www.biohorizons.com
BIRMINGHAM, Ala., Dec. 9, 2007/PRNewswire/ --
BioHorizons Implant Systems, Inc.relocated its global headquarters in Birmingham, Alabama, to a state-of-the-art, 44,000 square foot facility. The new facility, located at 2300 Riverchase Center, houses all administrative services, a newly formed manufacturing facility and a distribution center. The manufacturing facility will include machining, surface treatment and packaging services.
The new facility was required due to tremendous growth and an expanding product offering. BioHorizons’ President and CEO Steve Boggan commented, “We have experienced revenue growth of over 25% for each of the last six years and expect this growth rate to continue over the next several years. As a result, a new facility was required to house our expanding administrative and operations team. Further, the expanded facility allows for vertical integration of our product line to realize margin improvement and manufacturing efficiencies.” He continued by stating, “Having manufacturing in-house will also allow us to be even more responsive to the needs of our customers.”
About BioHorizons
BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. BioHorizons’ flagship External Implant System, a patented system of dental implants and related products, was launched in 1997. BioHorizons has a strong product offering of dental implants including internal hex, external hex, straight-walled, tapered, overdenture and one-piece implants. BioHorizons has signed exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. The company has a direct sales force in the U.S., Canada, Germany, Spain and United Kingdom. Products are distributed in the rest of the world via a network of independent distributors. The Company was purchased by HealthpointCapital in 2006.
www.biohorizons.com
About HealthpointCapital
HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the musculoskeletal sector — specifically orthopedics and dental.
With a cumulative 85 years of experience in healthcare technology, research and private investing, HealthpointCapital helps clients capitalize on the explosive growth and unique investment opportunities in one of the fastest growing sectors of the medical device industry.
HealthpointCapital manages $650 million of institutional capital.
www.healthpointcapital.com
BIRMINGHAM, Alabama, November 15, 2007 /PRNewswire/--
BioHorizons Implant Systems, Inc. has introduced a new line of Tapered Internal Implants that feature a unique thread design and proven surface engineering technology. This product introduction is the first from BioHorizons to address the tapered market segment which account for over 50% of the U.S. dental implant market.
The Tapered Internal Implants incorporate the Laser-Lok® precision laser collar surface treatment, which controls cellular growth and directs hard and soft tissue attachment onto dental implants. The result of over 15 years of evidence-based research and documented research studies, the patented 8 and 12 micron Laser-Lok® channels play a vital role in inhibiting epithelial downgrowth and attaching and retaining crestal bone. The implant design and surface treatment displayed improved hard and soft tissue response leading to excellent esthetic results in animal and human research studies.
"These new implants will offer supreme esthetic and clinical results to our global dental implant customers," commented Steve Boggan, President and CEO of BioHorizons. "Building on BioHorizons' commitment to science, innovation and service, we are pleased to bring such a novel product to the dental implant industry."
About BioHorizons
BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. BioHorizon's flagship External Implant System, a patented system of dental implants and related products, was launched in 1997. The Company was purchased by HealthpointCapital in 2006. BioHorizons has a strong product offering of dental implants including internal hex, external hex, overdenture and one-piece implants. BioHorizons has signed exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. The company has a direct sales force in the U.S., Canada, Germany, Spain and United Kingdom. Products are distributed in the rest of the world via a network of independent distributors.
NEW YORK, New York, and BIRMINGHAM, Alabama, August 22, 2006 /PRNewswire/ --
HEALTHPOINTCAPITAL, LLC ("HEALTHPOINTCAPITAL") announced today the purchase of BioHorizons Implant Systems, Inc. ("BioHorizons" or "Company"). BioHorizons designs, produces and distributes oral reconstructive devices including dental implants and tissue regeneration products. BioHorizons, located in Birmingham, Alabama, is one of the fastest-growing companies in the dental industry. Terms of the transaction were not disclosed.
"The dental implant market represents one of the fastest growing sectors in the medical technology industry," stated Mortimer Berkowitz III, President and Managing Director of HEALTHPOINTCAPITAL. "Dental implants offer patients superior clinical outcomes and improved esthetics compared to traditional treatments such as bridges and dentures. BioHorizons has a legacy of providing superior product quality and unmatched clinical service."
Steve Boggan, President and CEO of BioHorizons, commented that, "We are extremely pleased with the outcome for our shareholders, employees and customers. Our management team is excited about the opportunity to partner with HEALTHPOINTCAPITAL and expand our growth prospects in this attractive market."
Mr. Berkowitz becomes the Chairman of the Board and Mr. Boggan will continue as President, Chief Executive Officer and Director of the Company. BioHorizons plans to expand its headquarters in Birmingham and the management team will remain important shareholders.
First Albany Capital acted as exclusive financial advisor to BioHorizons in this transaction.
BioHorizons Implant Systems, Inc.
BioHorizons was founded in 1994 and has grown into one of the largest dental implant companies in the world with 112 employees. The Company has a strong product offering of dental implants including internal hex, external hex, overdenture and one-piece implants. BioHorizon's flagship External Implant System, a patented system of dental implants and related products, was launched in 1997. BioHorizons has signed exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. The Company has a direct sales force in the U.S., Canada, Germany, Spain and United Kingdom. Products are distributed in the rest of the world via a network of independent distributors.
HEALTHPOINTCAPITAL
HEALTHPOINTCAPITAL PARTNERS II, L.P. is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HEALTHPOINTCAPITAL has $500 million of institutional capital under management.
|
